HIGHLIGHTS
- who: Tadashi Nishimura and collaborators from the Department of Pulmonary Medicine, Mie Chuo Medical Center, Tsu, Mie, Japan Department of Pulmonary and Critical Care Medicine, Mie University Faculty and Graduate School of have published the article: Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy, in the Journal: (JOURNAL) of 11/01/2022
- what: This study shows that the efficacy of amrubicin in extensive-stage small cell lung cancer remains unchanged irrespective of previous treatment with immune checkpoint inhibitors. The results of this study showed that pretreatment . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.